文献速递脑血管病神经重症与神经感染

通过外部验证评估并比较max-ICH评分与ICH评分

Assessment and comparison of the max-ICH score and ICH score by external validation.
PubMed 文献 · Neurology · 2018-08-01

本研究为前瞻性观察研究,纳入372例自发性脑出血患者,其中71例(19%)接受了治疗限制或撤除生命支持。研究在3个月时用改良Rankin量表评估死亡与功能结局,比较ICH评分与max-ICH评分的AUC;结果显示两评分预后表现均良好(AUC范围0.80-0.86),且在全组及最大治疗亚组中两评分之间均无显著差异。

要点

  • max-ICH评分较ICH评分额外纳入口服抗凝相关条目,并设有16个评分等级,而ICH评分为11个。
  • 在372例自发性脑出血患者中,两评分对3个月死亡和不良功能结局的AUC范围均为0.80-0.86。
  • 全组及最大治疗亚组中,两评分对任一结局的AUC均无显著差异。

核心结论

  • 外部验证与直接比较显示,ICH评分与max-ICH评分的预后表现无有意义的差异。
  • 作者认为,可能需要简单评分之外的替代方法来改善用于患者诊疗决策的预后估计。

研究设计与样本

  • 前瞻性观察研究,纳入自发性脑出血患者,收集人口学与临床数据。
  • 共分析372例患者的结局,其中71例(19%)实施了治疗限制或撤除生命支持。
  • 以3个月改良Rankin量表评估死亡与功能结局,不良功能结局定义为改良Rankin量表评分4-6分。
  • 比较ICH评分与max-ICH评分对死亡和不良功能结局的受试者工作特征曲线下面积(AUC)。

主要发现

  • ICH评分与max-ICH评分在全组及最大治疗(即无治疗限制)亚组中,对3个月死亡和不良功能结局均显示良好预后表现,AUC范围0.80-0.86。
  • 全组中两评分对任一结局的AUC均无显著差异。
  • 最大治疗亚组中两评分对任一结局的AUC均无显著差异。

关键数值与推荐

  • ICH评分包含症状严重程度、年龄、血肿体积、血肿部位和脑室出血的测量。
  • max-ICH评分同样包含上述测量,并额外包含口服抗凝条目,设有16个评分等级,而ICH评分为11个评分等级。
  • 不良功能结局定义为改良Rankin量表评分4-6分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We tested the hypothesis that the maximally treated intracerebral hemorrhage (max-ICH) score is superior to the ICH score for characterizing mortality and functional outcome prognosis in patients with ICH, particularly those who receive maximal treatment. METHODS: Patients presenting with spontaneous ICH were enrolled in a prospective observational study that collected demographic and clinical data. Mortality and functional outcomes were measured by using the modified Rankin Scale at 3 months. The ICH score and max-ICH score incorporate measures of symptom severity, age, hematoma volume, hematoma location, and intraventricular hemorrhage, with the max-ICH score also including a term for oral anticoagulation and having 16 score categories vs 11 for the ICH score. We compared the area under the receiver operating characteristic curve (AUC) for the ICH score and max-ICH score for both mortality and poor functional outcome, defined as modified Rankin Scale scores 4-6. RESULTS: We analyzed outcomes for 372 patients, including 71 patients (19%) in whom care limitation/withdrawal of life support was instituted. Both the ICH score and max-ICH score showed good prognostic performance for 3-month mortality and poor functional outcomes in the full group as well as the subgroup with maximal treatment (i.e., no care limitations; AUC range 0.80-0.86), with no significant difference in AUC between the scores for either endpoint in either group. CONCLUSIONS: External validation with direct comparison of the ICH score and max-ICH score shows that their prognostic performance is not meaningfully different. Alternatives to simple scores are likely needed to improve prognostic estimates for patient care decisions.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schmidt FA, Liotta EM, Prabhakaran S, et al. Assessment and comparison of the max-ICH score and ICH score by external validation. Neurology. 2018. PMID: 30068631. doi:10.1212/WNL.0000000000006117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。